|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0705 - 0.0800|
|52 Week Range||0.0610 - 1.4500|
|Beta (5Y Monthly)||5.74|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul. 01, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD/CBG) and feminized hemp genetics, today reported financial results for the first quarter 2020. During the first quarter of 2020, Exactus is pleased it has reported record revenue as its investment into sales and marketing has begun to generate revenue and scale. The Company has significantly cut its monthly cash burn and has shifted its focus to rapidly generate revenue through bulk specialty ingredient sales.
Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the appointment of executive business leader, Julian Pittam to the Chairman of the Board. “Julian Pittam has been an investor and a friendly voice of wisdom since our inception, and we are honored to have him join as Chairman of the Board at this pivotal moment,” said Emiliano Aloi, Exactus Interim Chief Executive Officer. Julian started his career at Bankers Trust in sales and trading.
Exactus, Inc. (EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the institution of its Exactus Hemp Buyback Program in support of farmers who purchase seeds from the company. Exactus introduced its buyback program during this essential hemp planting season to aid farmers faced with hardships caused by the COVID-19 pandemic. With the launch of its buyback program, Exactus will buy back hemp biomass that meets their processing specifications at fair market value that meets the required specifications from farmers who purchase the company’s feminized CBD seeds.